At the molecular level, we noted a recurrent overlap between the AngioSwitch signature and several cellular signaling pathways that have been functionally implicated in RIP1-Tag2 tumor progression, including the PDGF receptor β and its ligand PDGF-BB [36] or endoglin [37]. The gene discussed is ENG; the disease is neoplasm.